Coronavirus

Economy

Health and Science

Biotech and Pharmaceuticals

Biotechnology

coronavirus|economy|health science|biotech and pha|biotechnology

coronavirus|economy|health science|biotech and pharmaceuticals|biotechnology

Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joined "Squawk Box" on Monday to discuss his latest op-ed in the Wall Street Journal in which he asks questions about the science behind the CDC's recommendation for six-feet social distancing guidance.